Cargando…
Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent
The broad number of health benefits which can be obtained from the long-term consumption of olive oil are attributed mainly to its phenolic fraction. Many olive oil phenolics have been studied deeply since their discovery due to their bioactivity properties, such as Hydroxytyrosol. Similarly, in the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213726/ https://www.ncbi.nlm.nih.gov/pubmed/30250008 http://dx.doi.org/10.3390/ijms19102899 |
_version_ | 1783367837265428480 |
---|---|
author | Segura-Carretero, Antonio Curiel, Jose Antonio |
author_facet | Segura-Carretero, Antonio Curiel, Jose Antonio |
author_sort | Segura-Carretero, Antonio |
collection | PubMed |
description | The broad number of health benefits which can be obtained from the long-term consumption of olive oil are attributed mainly to its phenolic fraction. Many olive oil phenolics have been studied deeply since their discovery due to their bioactivity properties, such as Hydroxytyrosol. Similarly, in the last decade, the special attention of researchers has been addressed to Oleocanthal (OC). This olive oil phenolic compound has recently emerged as a potential therapeutic agent against a variety of diseases, including cancer, inflammation, and neurodegenerative and cardiovascular diseases. Recently, different underlying mechanisms of OC against these diseases have been explored. This review summarizes the current literature on OC to date, and focuses on its promising bioactivities against different disease-targets. |
format | Online Article Text |
id | pubmed-6213726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62137262018-11-14 Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent Segura-Carretero, Antonio Curiel, Jose Antonio Int J Mol Sci Review The broad number of health benefits which can be obtained from the long-term consumption of olive oil are attributed mainly to its phenolic fraction. Many olive oil phenolics have been studied deeply since their discovery due to their bioactivity properties, such as Hydroxytyrosol. Similarly, in the last decade, the special attention of researchers has been addressed to Oleocanthal (OC). This olive oil phenolic compound has recently emerged as a potential therapeutic agent against a variety of diseases, including cancer, inflammation, and neurodegenerative and cardiovascular diseases. Recently, different underlying mechanisms of OC against these diseases have been explored. This review summarizes the current literature on OC to date, and focuses on its promising bioactivities against different disease-targets. MDPI 2018-09-24 /pmc/articles/PMC6213726/ /pubmed/30250008 http://dx.doi.org/10.3390/ijms19102899 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Segura-Carretero, Antonio Curiel, Jose Antonio Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent |
title | Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent |
title_full | Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent |
title_fullStr | Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent |
title_full_unstemmed | Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent |
title_short | Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent |
title_sort | current disease-targets for oleocanthal as promising natural therapeutic agent |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213726/ https://www.ncbi.nlm.nih.gov/pubmed/30250008 http://dx.doi.org/10.3390/ijms19102899 |
work_keys_str_mv | AT seguracarreteroantonio currentdiseasetargetsforoleocanthalaspromisingnaturaltherapeuticagent AT curieljoseantonio currentdiseasetargetsforoleocanthalaspromisingnaturaltherapeuticagent |